Hospital length of stay of nonvalvular atrial fibrillation patients who were administered Rivaroxaban versus Warfarin with and without pretreatment parenteral anticoagulants therapies

Hospital practice (1995)

Volumn 42, Issue 3, 2014, Pages 17-25

  Laliberté, François ^a   Pilon, Dominic ^a   Raut, Monika K ^a   Nelson, Winnie W ^a   Olson, William H ^a   Germain, Guillaume ^a   Schein, Jeff R ^a   Lefebvre, Patrick ^a  

^a GROUPE D ANALYSE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; MORPHOLINE DERIVATIVE; RIVAROXABAN; THIOPHENE DERIVATIVE; WARFARIN;

AGED; ATRIAL FIBRILLATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; STROKE; VERY ELDERLY;

ADMINISTRATION, INTRAVENOUS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MORPHOLINES; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; STROKE; THIOPHENES; WARFARIN;

EID: 84925226924     PISSN: 21548331     EISSN: None     Source Type: Journal    
DOI: 10.3810/hp.2014.08.1114     Document Type: Article

References (0)